Bioretec receives FDA breakthrough device designation for spinal interbody cage

Fact checked byGina Brockenbrough, MA

Key takeaways:

Bioretec received FDA breakthrough device designation for its RemeOs spinal interbody cage.
The cage is designed to restore intervertebral height during cervical spinal fusion.

Bioretec Ltd. received FDA breakthrough device designation for its RemeOs spinal interbody cage for use during intervertebral body fusion in the cervical spine, according to a press release.

The RemeOs spinal interbody cage is designed to restore intervertebral height for patients undergoing cervical spinal fusion, according to the release.

Spine doctor — Bioretec received FDA breakthrough device designation for its RemeOs spinal interbody cage. *Image: Adobe Stock*

“This designation gives us another validation of our expertise in creating innovative products for the unmet clinical needs in the orthopedic field,” Timo Lehtonen, CEO of Bioretec, said in the release. “I am enthusiastic about the future prospects and the market opportunities of this product, which is based on the patented hybrid technology.”

Published by:

Sources/Disclosures

Collapse

Source:

Press Release

Read more

Bioretec receives FDA breakthrough device designation for spinal interbody cage

Key takeaways:

Related Content